Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

BACKGROUND: Dermatomyositis and polymyositis (DM/PM) are rare, incurable inflammatory diseases that cause progressive muscle weakness and can be associated with increased medical resource use (MRU). When corticosteroid treatment is unsuccessful, patients may receive intravenous immunoglobulin (IVIg)...

Descripción completa

Detalles Bibliográficos
Autores principales: Knight, Tyler, Bond, T Christopher, Popelar, Breanna, Wang, Li, Niewoehner, John W, Anastassopoulos, Kathryn, Philbin, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440004/
https://www.ncbi.nlm.nih.gov/pubmed/28553129
http://dx.doi.org/10.2147/CEOR.S130992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440004/
https://www.ncbi.nlm.nih.gov/pubmed/28553129
http://dx.doi.org/10.2147/CEOR.S130992

Ejemplares similares